Recent studies have proposed the term “POLE/POLD1-associated tumor syndrome” to encompass a broader clinical spectrum beyond classical PPAP, recognizing that some patients carrying germline mutations in POLE or POLD1 may develop tumors without evidence of polyposis (33, 52). This evidence concerns the gene POLD1 and neoplastic syndrome.